Ordeniza, Lexie Zane Y.

HRN: 21-35-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2022
MUPIROCIN 2%, 15G (TUBE)
10/21/2022
10/28/2022
TOPICAL
Apply On Affected Area
Q8
IV Puncture Site Wounds
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: